✦ LIBER ✦
A Novel Reduced Toxicity Preparative Regimen For Hematopoietic Cell Allografting Combining Pentostatin (Nipent®) And Targeted Doses Of Intravenous Busulfan (Busulfex®) With Or Without Rituximab (PB ± R) Using CD4-Guided Immune Suppression: Preliminary Results Of An Ongoing Prospective Trial
✍ Scribed by M.A. Kharfan-Dabaja; J. Perkins; R. Cortes; L. Brand; H.F. Fernandez; J.L. Ochoa-Bayona; T. Field; L. Perez; C. McIsaac; B. Maddox; E. Ayala; R. Komrokji; J. Pinilla-Ibarz; E. Sotomayor; M. Tomblyn; C. Anasetti
- Book ID
- 116281575
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 56 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.